Physician profile
Allison Hull
NPI 1871782896
$2,241.59
in general payments reported to CMS, 2019-2025
16 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $97.70 · 2021: $234 · 2022: $258 · 2023: $446 · 2024: $529 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,427.00 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $140.20 | 2021-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $131.97 | 2021-2023 | |
| Abbott Laboratories | $124.20 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $83.25 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $78.57 | 2019-2025 | Pediarix, Rotarix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $53.73 | 2019-2020 | |
| Amgen INC. | $32.13 | 2025 | Otezla, Repatha |
| Pfizer INC. | $31.96 | 2019-2021 | |
| Cranial Technologies, INC | $31.24 | 2019-2023 | Doc Band |
| Hologic Sales and Service, LLC | $25.68 | 2024 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $19.64 | 2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $18.92 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.99 | 2020 | |
| Shire North American Group INC | $14.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $13.64 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.